{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T03:38:36Z","timestamp":1771472316307,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002966","name":"Sivas Cumhuriyet \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002966","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.braindev.2020.02.001","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T19:34:35Z","timestamp":1584041675000},"page":"418-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Coexistence of guanidinoacetate methyltransferase (GAMT) deficiency and neuroleptic malignant syndrome without creatine kinase elevation"],"prefix":"10.1016","volume":"42","author":[{"given":"M\u00fcge","family":"Ayano\u011flu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif","family":"Korgali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taner","family":"Sezer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halil Ibrahim","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma M\u00fcjgan","family":"S\u00f6nmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2020.02.001_b0005","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/bja\/85.1.129","article-title":"Neuroleptic malignant syndrome","volume":"85","author":"Adnet","year":"2000","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.braindev.2020.02.001_b0010","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2147\/NDT.S58677","article-title":"A rare case of neuroleptic malignant syndrome without elevated creatine kinase","volume":"10","author":"Nisijima","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.braindev.2020.02.001_b0015","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1176\/ajp.2007.164.6.870","article-title":"Neuroleptic malignant syndrome","volume":"164","author":"Strawn","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.braindev.2020.02.001_b0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3389\/fnut.2018.00115","article-title":"Safety of creatine supplementation in active adolescents and youth: a brief review","volume":"5","author":"Jagim","year":"2018","journal-title":"Front Nutr"},{"key":"10.1016\/j.braindev.2020.02.001_b0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.24953\/turkjped.2019.01.014","article-title":"A novel mutation in two cousins with guanidinoacetate methyltransferase (GAMT) deficiency presented with autism","volume":"61","author":"Ayd\u0131n","year":"2019","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.braindev.2020.02.001_b0030","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ymgme.2012.04.007","article-title":"Is low serum creatine kinase a nonspecific screening marker for creatine deficiency syndromes?","volume":"106","author":"Mercimek-Mahmutoglu","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.braindev.2020.02.001_b0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11011-006-9003-8","article-title":"Intrastriatal administration of guanidinoacetate inhibits Na+, K+-ATPase and creatine kinase activities in rat striatum","volume":"21","author":"Zugno","year":"2006","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.braindev.2020.02.001_b0040","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ymgme.2005.08.004","article-title":"1 HMR spectroscopy of the brain in CR transporter defect","volume":"86","author":"Sijens","year":"2005","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.braindev.2020.02.001_b0045","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ymgme.2010.06.021","article-title":"L-arginine:glycine amidinotransferase (AGAT) deficiency: clinical presentation and response to treatment in two patients with a novel mutation","volume":"101","author":"Edvardson","year":"2010","journal-title":"Mol Genet Metab"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760420300656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760420300656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:48:59Z","timestamp":1759952939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760420300656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0387760420300656"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2020.02.001","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coexistence of guanidinoacetate methyltransferase (GAMT) deficiency and neuroleptic malignant syndrome without creatine kinase elevation","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2020.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}